Today: 21 May 2026
Critical Metals (CRML) jumps after Greenland drill assays — what to watch next
15 January 2026
2 mins read

Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

New York, Jan 14, 2026, 19:27 EST — After-hours

  • Shares of Critical Metals jumped sharply in after-hours trading following the release of fresh drill assay results from its Tanbreez rare earth project in Greenland.
  • Investors are weighing if the new grades back an updated resource estimate and could speed up mine-planning efforts.
  • Attention turns to upcoming assay results and potential updates on offtake negotiations scheduled for early 2026.

Critical Metals Corp shares jumped roughly 33 percent to $17.93 in after-hours trading Wednesday, following a wild day that saw prices fluctuate between $13.03 and $19.05 on heavy volume. Around 60 million shares changed hands.

Washington remains focused on critical minerals supply chains as President Donald Trump announced Wednesday he would delay tariffs on rare earths and lithium for the time being. Instead, he urged officials to work on securing supplies from abroad — a stance that has investors closely watching miners and processors linked to non-China sources.

Critical Metals announced it has received the initial assay results from its 2025 drilling campaign at the Fjord Deposit and Upper Fjord zones of the Tanbreez rare earths project in Greenland. The program aims to expand known mineralization and feed into a revised resource estimate plus subsequent mine planning. CEO Tony Sage described the findings as “very encouraged,” highlighting what he called “consistent mineralization” throughout both areas. GlobeNewswire

Assays are lab tests that quantify the metal content in rock samples. Simply put, these numbers determine if a drill hole is purely geological data — or a figure investors and offtake buyers can actually value.

Critical Metals highlighted steady grades and a significant heavy rare earth element presence, along with strategic metals like gallium and hafnium. The company noted it is still awaiting further assay results from the 2025 field season.

Sage told Reuters late last month that Critical Metals aims to finalize the remaining 25% of offtake agreements for Tanbreez by early 2026 and is open to a U.S. government investment. “Would welcome it, even though we didn’t ask for it,” he said. The company plans to start mining in 2027, targeting first production by mid-2028, with capital costs around $500 million in Greenland. Meanwhile, its Austrian lithium project remains on hold, awaiting a rebound in lithium prices. Reuters

Still, the stock remains exposed to development risks. A mineral resource estimate doesn’t guarantee a mine, and slight shifts in grade, metallurgy, costs, or permitting schedules can upend project economics. On top of that, the company’s website lists a Form 144 filed Jan. 14 — a notice insiders submit before selling restricted stock — introducing more uncertainty in a stock that’s already volatile.

Volatility is baked into early-stage miners. News tends to come in fits and starts, and the market frequently treats each update as if it tells the entire story.

Thursday’s regular session will test if after-hours gains can stick as liquidity ramps back up. How much momentum follows through—or doesn’t—will be just as crucial as the drill tables themselves.

After the next open, investors will focus on two key near-term triggers: more assay results from Tanbreez, and updates on the timing for the revised resource estimate and mine-planning efforts. Progress on the remaining offtake agreements, which management expects in early 2026, will also draw attention.

Stock Market Today

  • Installed Building Products Stock: Revenue and Earnings Growth Slow Amid Market Underperformance
    May 20, 2026, 10:53 PM EDT. Installed Building Products' stock fell 15.9% to $208.38 over six months, underperforming the S&P 500's 13.3% gain. The slowdown in revenue growth to 2.4% annualized over two years contrasts with a 5-year trend of 11.7%. Earnings per share growth also lagged at 2.6%, reflecting persistent but subdued profitability. The stock trades at a forward price-to-earnings ratio of 20.8, indicating a fair valuation but limited near-term optimism. Analysts highlight a cautious outlook due to softer quarterly results and unproven impact from new offerings, suggesting investors may find better opportunities elsewhere.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
EchoStar Corporation (SATS) stock jumps nearly 6% as Dish vendor dispute hits FCC SpaceX review
Previous Story

EchoStar Corporation (SATS) stock jumps nearly 6% as Dish vendor dispute hits FCC SpaceX review

Fortescue Ltd stock ends higher after Zitara deal — what FMG investors watch next week
Next Story

Fortescue Ltd stock ends higher after Zitara deal — what FMG investors watch next week

Go toTop